Botanic Healthcare, a Hyderabad-based nutraceutical manufacturer, has successfully raised Rs 250 crore in its latest equity funding round. The funding was led by Stakeboat Capital, an investment firm, and included participation from Abakkus Four2Eight Opportunities Fund and DS Group, one of Stakeboat Capital’s Limited Partners (LPs).

The capital infusion will support Botanic Healthcare's expansion plans, allowing the company to strengthen its presence in the growing global nutraceutical segment. With the funds, Botanic Healthcare aims to consolidate its group entities and accelerate growth, targeting a significant 400 percent increase in business over the next three years.

The funding will help enhance Botanic Healthcare’s product portfolio, including new formulations, and facilitate strategic partnerships to widen its market reach. Furthermore, Botanic Healthcare plans to invest significantly in research and development (R&D) and clinical research capabilities through joint ventures and collaborations. 

The nutraceutical sector, with its increasing demand for health-focused products, presents a significant opportunity, and Botanic Healthcare is positioning itself as a key player in this space.